Dekkers Leaves Thermo Fisher for Bayer | GenomeWeb

NEW YORK (GenomeWeb News) – Marijn Dekkers has resigned his position as president, CEO, and member of the board of directors at Thermo Fisher Scientific to take over as CEO of German drug, chemicals, and life science giant Bayer.

Thermo Fisher has appointed current COO Marc Casper to become president, CEO, and board member effective Oct. 15, 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.